Cargando…
The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413
The novel selective D1 dopaminergic full agonists A-68930, A-77636 were discovered by the synthesis of molecules to probe the bioactive conformation of the partial agonist SKF-38393, by the use of this information to add D1 affinity and selectivity to a screening hit, and by traditional medicinal ch...
Autor principal: | Martin, Yvonne Connolly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412209/ https://www.ncbi.nlm.nih.gov/pubmed/25954518 http://dx.doi.org/10.1155/2011/424535 |
Ejemplares similares
-
SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy
por: Nguyen, Huy, et al.
Publicado: (2022) -
Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy
Publicado: (2022) -
Schedule of experiment R413
por: Jarlskog, G
Publicado: (1973) -
Progress report of R413
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974) -
Scheduling of R410/R413 in 1975
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)